Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Operations and Comprehensive Loss

v3.7.0.1
Consolidated Statement of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Expenses    
Research and development $ 5,003,640 $ 3,360,878
General and administrative 3,317,189 2,853,140
Operating Expenses 8,320,829 6,214,018
Other loss (income)    
Change in fair value of stock option and derivative liabilities (245,963) 2,341,660
Change in fair value of derivative liability due to change in warrant terms 295,456
Foreign exchange loss 7,355 13,838
Interest income (457) (108)
Other (income) loss (239,065) 2,650,846
Net and comprehensive loss for the year 8,081,764 8,864,864
Computation of basic loss per share    
Net and comprehensive loss for the year 8,081,764 8,864,864
Series B Preferred stock dividend 790,454 238,326
Computation of basic loss per share $ 8,872,218 $ 9,103,190
Basic and fully diluted loss per share $ 0.74 $ 0.83
Basic weighted average number of shares 12,047,079 10,948,481